Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0001171843-22-000984 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-11 | 2022-02-09 | ANIK | Finnerty Thomas | EVP, Human Resources | F - Tax | $30.72 | -3,149 | 18.7K | -14% | -$96.7K | |
| 2022-02-11 | 2022-02-09 | ANIK | Finnerty Thomas | EVP, Human Resources | A - Grant | $0.00 | +10.1K | 21.8K | +87% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-09 | F | D | 3,149 | $30.72 | 18,677 | D | — | — | (F2) Reflects an aggregate of 3,149 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to PSUs that vested on February 9, 2022. (F3) Reflects the closing price of the ANIK common stock on February 9, 2022, the trading day on which the vesting of PSUs gave rise to tax withholding obligations. |
| 2 | Common | Common Stock | 2022-02-09 | A | A | 10,125 | $0.00 | 21,826 | D | — | — | (F1) Reflects Performance Share Units ("PSUs") granted on February 26, 2019, and that the Compensation Committee of the Board of Directors determined on February 9, 2022 were earned. The PSUs vested in full on February 9, 2022 and were settled in shares of the Company's common stock on a one-for-one basis. |